Search results
Wall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
Shares of Immunocore Holdings PLC Sponsored ADR (IMCR) have gained 4.3% over the past four weeks to close the last trading session at $34.5, but there could still be a solid upside left in the stock
MKSI Q2 Earnings Call Highlights AI-Driven Capacity Ramp
MKS Inc. MKSI used its second-quarter 2026 call to frame AI-driven spending as the key force behind accelerating semiconductor and advanced-packaging demand. Management paired that view with plans
FISV Q2 Earnings Call Resets Outlook on Delays, Tech Spend
Fiserv, Inc. FISV used its second-quarter 2026 call to reset expectations, citing slower client implementations, weaker Argentina conditions and execution gaps. Chief executive officer (CEO) Takis
Microsoft Aktie: 30 Millionen Copilot-Nutzer
Vor sechs Wochen sprachen Analysten noch über Microsofts explodierende Rechenzentrums-Investitionen als Risikofaktor. Heute feiert…
Der Beitrag Microsoft Aktie: 30 Millionen Copilot-Nutzer erschien
Is the Options Market Predicting a Spike in FMC Stock?
Investors in FMC Corporation FMC need to pay close attention to the stock based on moves in the options market lately. That is because the August 21, 2026 $02.50 Call had some of the highest implied
Calumet Q2 Earnings Call Highlights
Key Points
- Interested in Calumet, Inc.? Here are five stocks we like better.
- Calumet reported $175 million in second-quarter adjusted EBITDA with tax attributes, driven by Specialty Products and
ARKO Q2 Earnings Call Highlights
Key Points
- Interested in ARKO Corp.? Here are five stocks we like better.
- Second-quarter profitability softened as elevated gasoline prices pressured fuel volumes and in-store spending: Adjusted
DroneShield Aktie: 28,48 Prozent Wochenplus
Die Aktie von DroneShield hat sich von den Turbulenzen des Sommers spürbar erholt. Nach…
Der Beitrag DroneShield Aktie: 28,48 Prozent Wochenplus erschien zuerst auf kapitalmarktexperten.de.
Quelle k
Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending?
Alignment Healthcare, Inc. ALHC strengthened its 2026 outlook after a second quarter marked by higher membership, better-than-expected earnings and improving medical-cost performance. The first half
Is ZETA Worth Buying Now as Growth Surges but Valuation Stays Rich?
Zeta Global Holdings Corp. ZETA is delivering faster growth, deeper customer spending and stronger cash generation, but its valuation already reflects a meaningful portion of that progress.
The
FUL vs. NVZMY: Which Stock Is the Better Value Option?
Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for
GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution
Globus Medical, Inc. GMED used its second-quarter 2026 call to emphasize margin execution and continued spine share gains, while management flagged Nevro and Enabling Technologies as risks within
Tyson Cuts Beef Outlook as Q3 Volume Slumps, What It Means for 2026
Tyson Foods, Inc. TSN entered the final stretch of fiscal 2026 with a sharper split across its portfolio. Chicken and Prepared Foods remained productive, but worsening Beef economics pressured
Is ASTE Stock a Buy Now on Cheap Valuation Despite Execution Risk?
Astec Industries, Inc. ASTE presents a split investment picture. Its valuation sits below key historical and industry benchmarks, while infrastructure demand, backlog growth and a larger aftermarket
DEC Q2 Earnings Call Spotlights New Oklahoma Drilling Plan
Diversified Energy Company DEC used its second-quarter 2026 earnings call to frame operated drilling as an extension of its acquisition-and-optimization model, not a strategic pivot. Management said
RVLV Q2 Beat Masks Tariff Boost as 2026 Investment Spending Rises
Revolve Group, Inc. RVLV beat second-quarter earnings expectations as sales growth stayed broad and underlying merchandising economics improved. Yet tariff refunds amplified reported profitability
TechTarget Q2 Earnings Call Highlights
Key Points
- Interested in TechTarget, Inc.? Here are five stocks we like better.
- Revenue declined amid cautious customer spending: Second-quarter revenue fell 3.2% year over year to $116.1
SOUN Dips 16.9% in 3 Months. Can Stronger Growth Reverse the Slide?
SoundHound AI, Inc. SOUN shares have lost 16.9% in the past three months even as second-quarter revenues, enterprise adoption and operating metrics improved. That split between price action and
Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?
Cardinal Health CAH is scheduled to report fourth-quarter fiscal 2027 results on Aug. 11, before market open.
The Zacks Consensus Estimate for sales is pegged at $65.61 billion, implying 9.1%
COP Q2 Earnings Call Reinforces 2029 Free Cash-Flow Path
ConocoPhillips COP used its second-quarter 2026 earnings call to reinforce a $7 billion free-cash-flow inflection by 2029, with lower capital spending and higher cash flow from major projects